Quantcast

Latest transplantation Stories

2014-08-29 23:09:46

Hair restoration client shares unbelievable physical and emotional transformation. (PRWEB) August 29, 2014 August is National Hair Loss Awareness Month and there is no better time for men and women concerned with thinning hair and balding to take action. As National Hair Loss Awareness Month comes to a close, North America's largest provider of all proven hair restoration solutions, Hair Club, encourages those noticing hair loss to explore their options. Hair Club offers several...

2014-08-28 12:29:36

MILWAUKEE, Aug. 28, 2014 /PRNewswire-USNewswire/ -- BloodCenter of Wisconsin's Diagnostic Laboratories today announced the availability of an innovative Erythroid Chimerism test to monitor erythroid lineage chimerism in patients with sickle cell disease (SCD) following allogeneic bone marrow transplantation. This allows the physician to directly gauge the success of the transplant in these patients and provides physicians with actionable information to guide patient care. Sickle cell...

2014-08-18 16:25:38

LONDON, Aug. 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Lung Transplantation-Pipeline Insights, 2014https://www.reportbuyer.com/product/2278637/-Lung-Transplantation-Pipeline-Insights-2014.htmlSUMMARYDelveInsight's," Lung Transplantation-Pipeline Insights, 2014", report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that...

2014-08-08 11:20:47

Cell Transplantation Center of Excellence for Aging and Brain Repair Induced immunorejection may eliminate tumors post-cell transplantation Recent studies have shown that transplanting induced pluripotent stem cell-derived neural stem cells (iPS-NSCs) can promote functional recovery after spinal cord injury in rodents and non-human primates. However, a serious drawback to the transplantation of iPS-NSCs is the potential for tumor growth, or tumorogenesis, post-transplantation. In an...

2014-08-04 08:28:32

Significant company milestones include completion of the Phase 2 PUNCH(TM) CD clinical trial and FDA designation of RBX2660 as Orphan Drug and Fast Track ROSEVILLE, Minn., Aug 4, 2014 /PRNewswire/ -- Rebiotix Inc. announced this morning that it has raised a total of $25 million in Series B Funding. The total funds raised since inception by the clinical-stage biotechnology company founded in 2011 is $30 million. Rebiotix will use the additional funds to support pivotal clinical...

2014-07-31 23:01:56

Dr. Parsa Mohebi, founder of US Hair Restoration with hair transplant centers in Beverly Hills and Los Angeles, delivered a series of well-received presentations on his revolutionary techniques for hair restoration that inspired an international audience to adopt these new methods. Los Angeles, CA (PRWEB) July 31, 2014 Dr. Mohebi was asked about his experience attending these international scientific meetings, “I love the experience of traveling and sharing what we learned through...

2014-07-31 12:08:01

Dana-Farber Cancer Institute Study in NEJM reviews 10 years of data, argues for expansion of newborn screening Children born with so-called "bubble boy" disease have the best chance of survival if they undergo a hematopoietic stem cell transplant as soon after birth as possible, according to a detailed analysis of 10 years of outcome data by researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center. These findings, the researchers say, argue for expanding newborn...

2014-07-30 12:30:36

Findings presented at the 2014 World Transplant Congress SAN FRANCISCO, July 30, 2014 /PRNewswire/ -- A study presented at the 2014 World Transplant Congress evaluated the safety and efficacy of CSL Behring's C1 Inhibitor (C1-INH) concentrate in preventing antibody-mediated rejection following kidney transplants in highly sensitized patients. C1-INH is a human protein and an important inhibitor of the complement system. http://photos.prnewswire.com/prnvar/20100914/PH63692LOGO The...

2014-07-28 23:02:51

New professional network announced during the 2014 World Transplant Congress and includes hundreds of industry-leading physicians and scientists. Mount Laurel, NJ (PRWEB) July 28, 2014 The American Society of Transplantation (AST), representing the majority of professionals engaged in the field of organ transplantation, today announced the launch of the Transplantation and Immunology Research Network (TIRN), a professional network established to advance transplantation and immunology...

2014-07-28 13:28:02

University of Oxford Oxford University scientists have shown that a powerful drug given at the time of a kidney transplant operation not only halves the early risk of rejection, but that it also allows a less toxic regimen of anti-rejection drugs to be used after the operation. The key results are reported in The Lancet and presented at the World Transplant Congress in San Francisco today. They will help doctors faced with a difficult transplant conundrum: the powerful combinations of...


Latest transplantation Reference Libraries

Bone Marrow Transplantation (journal)
2012-06-04 20:00:41

Bone Marrow Transplantation is a peer-reviewed medical journal published monthly by Nature Publishing Group. As of May 2012, the editor-in-chief is J.M. Goldman (UK). The journal publishes high quality, original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation in humans. The broad scope of the journal thus encompasses topics such as stem cell biology, kinetics and cytokine control, transplantation immunology, HLA and matching...

More Articles (1 articles) »
Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related